Persistent Depressive Disorder – Epidemiology – Mature Markets

Clarivate Epidemiology’s coverage of persistent depressive disorder comprises epidemiological estimates of key patient populations in 45 countries worldwide. We report the prevalence of persistent depressive disorder for each country, as well as annualized case counts projected to the national population.

Most patient populations are forecast over a period of 20 years for the major mature pharmaceutical markets of the United States, Europe, and Japan and 10 years for the other countries covered in this report. In addition to forecasting prevalent patient populations, we estimate the number of drug-treatment opportunities in specific lines of therapy in the major mature pharmaceutical markets.

Clarivate Epidemiology’s persistent depressive disorder forecast will answer the following questions:

  • Of all people with persistent depressive disorder, how many in each of the major mature pharmaceutical markets have been formally diagnosed?
  • Of all people diagnosed with persistent depressive disorder, how many in each of the major mature pharmaceutical markets are drug-treated?
  • How will demographic trends, such as population aging and improving life expectancy, affect the epidemiology of persistent depressive disorder over the forecast period?

All forecast data are available on the Clarivate Insights Platform in tabular format, with options to download to MS Excel. All populations are accompanied by a comprehensive description of the methods and data sources used, with hyperlinks to external sources. A summary evidence table generated as part of our systematic review of the epidemiological literature is also provided for full transparency into research and methods. In addition, we provide a graph depicting the patient flow between or within different disease states for the major mature pharmaceutical markets. These patient-flow diagrams are provided at the regional level but may be requested for any specific country or forecast year.

Clarivate Epidemiology forecasts the following persistent depressive disorder patient population:

  • Total prevalent cases

Note: Coverage may vary by country.

Table of contents

  • Persistent Depressive Disorder - Epidemiology - Mature Markets
    • Introduction
      • Key Findings
      • Total Prevalence of Persistent Depressive Disorder per 1,000 Among People Aged 15+ in 2020 and 2040ttttttttt
      • Relative Sizes of the Factors Contributing to the Trend in Total Prevalent Cases of Persistent Depressive Disorder over the Next Twenty Yearsttttttttt
    • Epidemiology Data
    • Methods
      • Total 12-Month Prevalent Cases
    • Reference Materials
      • Literature Review
        • Studies Included in the Analysis of Persistent Depressive Disorder
      • Risk/Protective Factors
        • Risk/Protective Factors for Persistence Depressive Disorder
      • Bibliography
      • Glossary